NuvoBio
Business Services · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(613) 455-0126Website
www.nuvobio.comRevenue
<$5 MillionIndustry
About NuvoBio
NuvoBio is a pioneering peptide therapeutics company that utilizes its innovative Darwin AI Peptide Discovery Platform to develop a pipeline of advanced therapies. Focused on addressing chronic diseases, NuvoBio’s AI-driven approach accelerates drug discovery by enhancing peptide specificity and reducing off-target risks. The company aims to create novel peptides for diverse applications in therapeutics, diagnostics, and drug delivery, thereby revolutionizing the biotechnology and medicine fields. With a talented team of research scientists and engineers, NuvoBio is dedicated to delivering safer and more effective treatments for high-impact health challenges.Explore more
NuvoBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to NuvoBio
Compare insights from companies similar to NuvoBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NuvoBio Tech Stack
A closer look at the technologies used by NuvoBio
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NuvoBio
Sign Up For FreeTo access detailed company insights
NuvoBio is a pioneering peptide therapeutics company that utilizes its innovative Darwin AI Peptide Discovery Platform to develop a pipeline of advanced therapies. Focused on addressing chronic diseases, NuvoBio’s AI-driven approach accelerates drug discovery by enhancing peptide specificity and reducing off-target risks. The company aims to create... Read More
